Keywords: Sucampo, Takeda, Amitiza, Dispute, Court ruling, Rescula

Sucampo fails in Amitiza arbitration with Takeda

Article | 09 July 2012

Print This

US drugmaker Sucampo Pharmaceuticals (Nasdaq: SCMP) says that it has received a final binding decision on its claims in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in